wyeth Resources | BNET
On The Insider: Sarah Jessica Parker's Mole Removed

BNET Industries

Wyeth (WYE) is in the Pharma Industry

Revenue
Dec 31 2007
$22.3B
Profit
Dec 31 2007
$4.6B
Market Cap
Jul 23 2008
$60.7B

Latest News and Analysis

  • Incorporated: 1926
  • CEO: Mr. Bernard J. Poussot

Wyeth is engaged in the discovery, development, manufacture, distribution and sale of a line of products in three primary businesses: Wyeth Pharmaceuticals (Pharmaceuticals), Wyeth Consumer Healthcare (Consumer Healthcare) and Fort Dodge Animal Health (Animal Health). Co.'s Pharmaceutical products include branded human ethical pharmaceuticals, biotechnology products, vaccines and nutrition products, while its Consumer Healthcare products include analgesics, cough/cold/allergy remedies, nutritional supplements, and hemorrhoidal, asthma and personal care items sold over-the-counter, and its Animal Health products include vaccines, pharmaceuticals, parasite control and growth implants.

Key Competitors

Wyeth Company Info

Board of Directors

Mr. Robert Essner

Chairman

Mr. Bernard J. Poussot

Mr. Gary L. Rogers

Mr. Michael J. Critelli

Mr. John R. Torell III

Mr. Robert M. Amen

Mr. John D. Feerick

Dr. Frances D. Fergusson Ph.D.

Mr. Victor F. Ganzi

Dr. Robert S. Langer Sc.D.

Mr. John P. Mascotte

Mr. Raymond J. McGuire

Dr. Mary Lake Polan Ph.D.

Contact Information

Five Giralda Farms

Madison, NJ

http://www.wyeth.com

973 660-5000

NAICS Code

Pharmaceutical Preparation Manufacturing: 325412